Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The objective is to assess the efficacy and safety of BAY 59-7939 10 mg once daily dosing in prevention of VTE in men and women aged 18 years or above undergoing elective total knee replacement.
Critère d'inclusion
- Prevention of venous thromboembolism